Overexpression of Msx1 in Mouse Lung Leads to Loss of Pulmonary Vessels Following Vascular Hypoxic Injury
Pulmonary arterial hypertension (PAH) is a progressive lung disease caused by thickening of the pulmonary arterial wall and luminal obliteration of the small peripheral arteries leading to increase in vascular resistance which elevates pulmonary artery pressure that eventually causes right heart fai...
Main Authors: | James West, Anandharajan Rathinasabapathy, Xinping Chen, Sheila Shay, Shanti Gladson, Megha Talati |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2306 |
Similar Items
-
Evidence for Multiple Origins of De Novo Formed Vascular Smooth Muscle Cells in Pulmonary Hypertension: Challenging the Dominant Model of Pre-Existing Smooth Muscle Expansion
by: Xuran Chu, et al.
Published: (2021-08-01) -
Novel Pyrazolo[3,4-b] Pyridine Derivative (HLQ2g) Attenuates Hypoxic Pulmonary Hypertension via Restoring cGKI Expression and BMP Signaling Pathway
by: Lijun Li, et al.
Published: (2021-10-01) -
Ezrin regulating the cytoskeleton remodelling is required for hypoxia-induced Myofibroblast proliferation and migration
by: Bin eYi, et al.
Published: (2015-03-01) -
Thin Air, Thick Vessels: Historical and Current Perspectives on Hypoxic Pulmonary Hypertension
by: Jason M. Young, et al.
Published: (2019-05-01) -
Physiologic and molecular consequences of endothelial Bmpr2 mutation
by: Crona Daniel, et al.
Published: (2011-06-01)